Plants of Ruskin (d.b.a. AltMed Florida) Receives Authorization to Commence Medical Cannabis Cultivation in Florida
Official approval comes as AltMed Florida works to complete phase-one of its state-of-the-art 150,000-square-foot cultivation facility located near Tampa and Sarasota
SARASOTA, FLA – Nov.20, 2017 –The Florida Department of Health has granted authorization for Plants of Ruskin, doing business as (d.b.a.) AltMed Florida, to begin cultivating medical cannabis for Florida patients.
The confirmation from Florida’s Office of Medical Marijuana Use “to begin cultivating low-THC and full medical cannabis at its cultivation facility located at 5909 Highway 41 North, Apollo Beach, Florida” is a defining moment for the company and for Florida patients.
“We have worked diligently to build what we believe will be the most advanced indoor cultivation facility in Florida, and one of the finest in the country,” said AltMed Florida CEO John Tipton. “We are completing construction of our 50,000-square-foot phase-1 now. We will start seeding immediately, commencing production of our comprehensive portfolio of medical cannabis products. Phase-2 and phase-3, with construction starting next year, will expand our facility to 150,000 square feet.
Earlier this year Plants of Ruskin and AltMed Enterprises partnered to combine AltMed’s medical cannabis research and development, extraction and delivery expertise, with Plants of Ruskin’s multi-generational agricultural experience.
“AltMed Enterprises was born in Florida and through years of research and the diligent work of our expert team we have developed a pipeline of next-generation medical cannabis products in Arizona,” said AltMed Enterprises CEO Michael Smullen. “We are thrilled to have the opportunity to provide access to these proven products, through AltMed Florida, to Florida patients.”
As one of only 13 Medical Marijuana Treatment Center (MMTC) licensees in Florida, Plants of Ruskin (d.b.a. AltMed Florida) is poised to become a leader in serving Florida’s medical cannabis patients.
MüV™ cannabis infused products will be available by delivery and exclusively in “MüV by AltMed Florida” dispensaries throughout the state. AltMed Florida expects to have a minimum of six dispensaries serving east and west coast Florida by the end of 2018.
Products are expected to be available for Florida patients early in 2018.
About Plants of Ruskin
With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.
About AltMed Enterprises
Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated company that brings pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.
Forward-Looking Statements – To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.
Media Contact: Colin Trethewey / PRmediaNow / 813.480.1354 / Colin@PRmediaNow.com